UNSPECIFIED (1993) INTERACTIONS BETWEEN INTERFERON-GAMMA AND RETINOIC ACID WITH TRANSFORMING GROWTH-FACTOR-BETA IN THE INDUCTION OF IMMUNE RECOGNITION MOLECULES. CANCER IMMUNOLOGY IMMUNOTHERAPY, 37 (2). pp. 112-118. ISSN 0340-7004

Full text not available from this repository.

Abstract

The cell-surface expression of major histocompatibility (MHC) antigens and the adhesion molecule intercellular adhesion molecule1 (ICAM-1) is essential for target cell recognition by T lymphocytes. The expression of both classes of molecule is induced by various cytokines, notably interferon gamma (IFNgamma). Since transforming growth factor beta (TGFbeta) has been recently reported to antagonise HLA-DR induction by IFNgamma we have examined, using a number of murine and human cell lines, the effect of TGFbeta on IFNgamma-induced MHC class I and class II and ICAM-1 expression. All of the cell lines tested expressed elevated class I MHC following IFNgamma treatment. Class II MHC induction was seen on most but not all of the cells, the exceptions being among a panel of human colorectal carcinoma cell lines. A striking difference between cells of different origin was noted in the response to TGFbeta. TGFbeta was found to antagonise IFNgamma-induced class I and class II MHC expression on C3H 10T1/2 murine fibroblasts, early-passage BALB/c mouse embryo fibroblasts, a murine oligodendroglioma cell line, and on MRC5 human fibroblasts and two human glioblastoma cell lines. Class II MHC was much more strongly inhibited (sometimes completely) than class I MHC. TGFbeta also inhibited induction of class I MHC expression by IFNalpha. However, TGFbeta did not inhibit class I or class II MHC induction by IFNgamma in any of the nine colorectal carcinoma cell lines, although two of five of the lines tested were growth-inhibited by TGFbeta. On the other hand, human ICAM-1 induction by IFNgamma was not affected by simultaneous treatment with TGFbeta in any of the cell lines. The down-regulation of IFNgamma-induced MHC antigens by TGFbeta is not, therefore, the result of a general antagonism of IFNgamma. Retinoic acid has recently been reported to induce ICAM-1 expression on human tumour cells. We have confirmed this observation on MRC5, and the two human glioblastoma cell lines, however six colorectal carcinoma cell lines tested did not respond. In contrast to IFNgamma-induced ICAM-1 expression, retinoic-acid-induced ICAM-1 expression was inhibited by TGFbeta on two of the three responsive lines.

Item Type:	Journal Article
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) Q Science > QR Microbiology > QR180 Immunology
Journal or Publication Title:	CANCER IMMUNOLOGY IMMUNOTHERAPY
Publisher:	SPRINGER VERLAG
ISSN:	0340-7004
Date:	July 1993
Volume:	37
Number:	2
Number of Pages:	7
Page Range:	pp. 112-118
Publication Status:	Published
URI:	http://wrap.warwick.ac.uk/id/eprint/21242

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item